Sign inGet started

COEP

Coeptis Therapeutics Holdings, Inc.CIK 1759186 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
9

AI insights for COEP PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for COEP
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Cogley BrianChief Financial Officer4$3.4K$02026-02-11
DeSilva TaraDirector6$1.3K$02026-02-11
Cochran Christopher P.Director5$5.4K$02026-02-11
Sheehy Christine EliseVP Compliance and Secy4$0$02026-02-11
Yerace Daniel AlexanderVP of Operations5$7.5K$02026-02-11
Mehalick DavidCEO and President10$16.7K$02026-02-11
Calise ChrisDirector, 10% Owner7$10.9K$02026-02-11
Deschamps PhilippeDirector4$0$02026-02-11
Salkind GeneDirector7$38.1K$02026-02-11

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
DeSilva TaraDirector A Award2026-02-112026-02-133,250— $08,950SEC↗
DeSilva TaraDirector M Exercise2026-02-112026-02-135,700$10.56 $60.2K8,950SEC↗
Yerace Daniel AlexanderVP Operations A Award2026-02-112026-02-1320,000— $070,531SEC↗
Yerace Daniel AlexanderVP Operations M Exercise2026-02-112026-02-1310,000$10.41 $104.1K70,531SEC↗
Salkind GeneDirector A Award2026-02-112026-02-133,250— $013,161SEC↗
Salkind GeneDirector M Exercise2026-02-112026-02-135,700$10.56 $60.2K13,161SEC↗
Sheehy Christine EliseVP Compliance and Secy A Award2026-02-112026-02-1312,500— $064,031SEC↗
Sheehy Christine EliseVP Compliance and Secy M Exercise2026-02-112026-02-131,000$10.56 $10.6K64,031SEC↗
Cochran Christopher P.Director A Award2026-02-112026-02-133,250— $08,950SEC↗
Cochran Christopher P.Director M Exercise2026-02-112026-02-135,700$10.56 $60.2K8,950SEC↗
Mehalick DavidCEO and President A Award2026-02-112026-02-1351,250— $0330,192SEC↗
Mehalick DavidCEO and President M Exercise2026-02-112026-02-13148,875$7.05 $1.05M330,192SEC↗
Calise ChrisDirector A Award2026-02-112026-02-133,250— $0368,741SEC↗
Calise ChrisDirector M Exercise2026-02-112026-02-135,700$10.56 $60.2K368,741SEC↗
Cogley BrianChief Financial Officer M Exercise2026-02-112026-02-1310,000$10.56 $105.6K22,500SEC↗
Cogley BrianChief Financial Officer A Award2026-02-112026-02-1312,500— $022,500SEC↗
Deschamps PhilippeDirector A Award2026-02-112026-02-133,250— $08,950SEC↗
Deschamps PhilippeDirector M Exercise2026-02-112026-02-135,700$10.56 $60.2K8,950SEC↗
Calise ChrisDirector A Award deriv2025-03-042025-03-065,700— $08,950SEC↗
Cochran Christopher P.Director A Award deriv2025-03-042025-03-065,700— $08,950SEC↗
DeSilva TaraDirector A Award deriv2025-03-042025-03-065,700— $08,950SEC↗
Mehalick DavidCEO and President A Award deriv2025-03-042025-03-0628,875— $0200,125SEC↗
Salkind GeneDirector A Award deriv2025-03-042025-03-065,700— $08,950SEC↗
Sheehy Christine EliseVP Compliance and Secy A Award deriv2025-03-042025-03-061,000— $013,500SEC↗
Yerace Daniel AlexanderVP of Operations A Award deriv2025-03-042025-03-065,000— $025,000SEC↗
Cogley BrianChief Financial Officer A Award deriv2025-03-042025-03-0610,000— $022,500SEC↗
Deschamps PhilippeDirector A Award deriv2025-03-042025-03-105,700— $08,950SEC↗
DeSilva TaraDirector P Buy2024-01-122024-01-161,800$0.58 $1.0K32,266SEC↗
DeSilva TaraDirector P Buy2024-01-122024-01-16466$0.56 $26130,466SEC↗
Cogley BrianChief Financial Officer P Buy2024-01-102024-01-175,000$0.67 $3.4K30,000SEC↗
Mehalick DavidCEO and President P Buy2024-01-082024-01-096,000$0.67 $4.0K2,768,611SEC↗
Mehalick DavidCEO and President P Buy2024-01-082024-01-0914,004$0.66 $9.2K2,782,615SEC↗
Cochran Christopher P.Director P Buy2024-01-052024-01-097,000$0.77 $5.4K37,000SEC↗
Mehalick DavidCEO and President P Buy2024-01-052024-01-095,050$0.69 $3.5K2,762,611SEC↗
Salkind GeneDirector P Buy2024-01-052024-01-0911,600$0.69 $8.0K284,056SEC↗
Yerace Daniel AlexanderVP of Operations P Buy2024-01-052024-01-0910,850$0.69 $7.5K1,071,455SEC↗
Mehalick DavidCEO and President G Gift2023-12-072023-12-11700,000— $02,757,561SEC↗
Salkind GeneDirector P Buy2023-08-292023-08-304,006$1.01 $4.0K4,046SEC↗
Salkind GeneDirector P Buy2023-08-252023-08-3028,638$0.91 $26.1K28,638SEC↗
Calise ChrisDirector P Buy2023-08-232023-08-312,582$0.94 $2.4K1,464,897SEC↗
Calise ChrisDirector P Buy2023-08-232023-08-319,000$0.94 $8.5K1,462,315SEC↗
Calise ChrisDirector A Award deriv2023-01-272023-01-3130,000— $030,000SEC↗
Cochran Christopher P.Director A Award deriv2023-01-272023-01-3130,000— $030,000SEC↗
Deschamps PhilippeDirector A Award deriv2023-01-272023-01-3130,000— $030,000SEC↗
DeSilva TaraDirector A Award deriv2023-01-272023-01-3130,000— $030,000SEC↗
Mehalick DavidCEO and President A Award deriv2023-01-272023-01-31250,000— $0250,000SEC↗
Mehalick DavidCEO and President A Award deriv2023-01-272023-01-31375,000— $0375,000SEC↗
Salkind GeneDirector A Award deriv2023-01-272023-01-3130,000— $030,000SEC↗
Sheehy Christine EliseCFO and Secretary A Award deriv2023-01-272023-01-31200,000— $0200,000SEC↗
Yerace Daniel AlexanderVP of Operations A Award deriv2023-01-272023-01-31200,000— $0200,000SEC↗
Calise ChrisDirector, 10% Owner A Award deriv2022-10-282022-11-013,000,000$1.00 $3.00M3,000,000SEC↗
Mehalick DavidCEO and President S Sale2021-11-162021-11-181,200,000— $01,800,000SEC↗